{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T16:48:40Z","timestamp":1791910120691,"version":"4.3.4"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T00:00:00Z","timestamp":1783728000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T00:00:00Z","timestamp":1791849600000},"content-version":"vor","delay-in-days":94,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Major scientific research Project of the Health Commission of Jiangsu Province","award":["ZD2021002"],"award-info":[{"award-number":["ZD2021002"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-61819-6","type":"journal-article","created":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T16:34:54Z","timestamp":1783787694000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Associations between the intratumoral microbiome and the host transcriptome in bladder cancer and their implications for prognostic prediction"],"prefix":"10.1038","volume":"16","author":[{"given":"Jiayu","family":"Gu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Menglin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhihao","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minhao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ye","family":"Hua","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianfeng","family":"Shao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-7425-8751","authenticated-orcid":false,"given":"Ninghan","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,11]]},"reference":[{"key":"61819_CR1","doi-asserted-by":"publisher","first-page":"1844","DOI":"10.1097\/cm9.0000000000000871","volume":"133","author":"XB Qian","year":"2020","unstructured":"Qian, X. B. et al. A guide to human microbiome research: study design, sample collection, and bioinformatics analysis. Chin. Med. J. (Engl). 133, 1844\u20131855. https:\/\/doi.org\/10.1097\/cm9.0000000000000871 (2020).","journal-title":"Chin. Med. J. (Engl)"},{"key":"61819_CR2","doi-asserted-by":"publisher","first-page":"1156","DOI":"10.1126\/science.aah5043","volume":"357","author":"LT Geller","year":"2017","unstructured":"Geller, L. T. et al. Potential role of intratumor bacteria in mediating tumor resistance to the chemotherapeutic drug gemcitabine. Science 357, 1156\u20131160. https:\/\/doi.org\/10.1126\/science.aah5043 (2017).","journal-title":"Science"},{"key":"61819_CR3","doi-asserted-by":"publisher","first-page":"2378","DOI":"10.1158\/2159-8290.Cd-21-0324","volume":"11","author":"RJ Knippel","year":"2021","unstructured":"Knippel, R. J., Drewes, J. L. & Sears, C. L. The cancer microbiome: Recent highlights and knowledge gaps. Cancer Discov. 11, 2378\u20132395. https:\/\/doi.org\/10.1158\/2159-8290.Cd-21-0324 (2021).","journal-title":"Cancer Discov"},{"key":"61819_CR4","doi-asserted-by":"publisher","first-page":"17","DOI":"10.3322\/caac.21763","volume":"73","author":"RL Siegel","year":"2023","unstructured":"Siegel, R. L., Miller, K. D., Wagle, N. S. & Jemal, A. Cancer statistics, 2023. CA Cancer J. Clin. 73, 17\u201348. https:\/\/doi.org\/10.3322\/caac.21763 (2023).","journal-title":"CA Cancer J. Clin."},{"key":"61819_CR5","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1038\/s41572-023-00468-9","volume":"9","author":"L Dyrskj\u00f8t","year":"2023","unstructured":"Dyrskj\u00f8t, L. et al. Bladder cancer. Nat. Rev. Dis. Primers. 9, 58. https:\/\/doi.org\/10.1038\/s41572-023-00468-9 (2023).","journal-title":"Nat. Rev. Dis. Primers"},{"key":"61819_CR6","doi-asserted-by":"publisher","first-page":"1471","DOI":"10.1099\/jmm.0.001058","volume":"68","author":"H Bi","year":"2019","unstructured":"Bi, H. et al. Urinary microbiota\u2014a potential biomarker and therapeutic target for bladder cancer. J. Med. Microbiol. 68, 1471\u20131478. https:\/\/doi.org\/10.1099\/jmm.0.001058 (2019).","journal-title":"J. Med. Microbiol."},{"key":"61819_CR7","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1146\/annurev-immunol-020711-074937","volume":"30","author":"K Honda","year":"2012","unstructured":"Honda, K. & Littman, D. R. The microbiome in infectious disease and inflammation. Annu. Rev. Immunol. 30, 759\u2013795. https:\/\/doi.org\/10.1146\/annurev-immunol-020711-074937 (2012).","journal-title":"Annu. Rev. Immunol."},{"key":"61819_CR8","doi-asserted-by":"publisher","first-page":"2320280","DOI":"10.1080\/19490976.2024.2320280","volume":"16","author":"MS Cruz","year":"2024","unstructured":"Cruz, M. S., Tintelnot, J. & Gagliani, N. Roles of microbiota in pancreatic cancer development and treatment. Gut Microbes. 16, 2320280. https:\/\/doi.org\/10.1080\/19490976.2024.2320280 (2024).","journal-title":"Gut Microbes"},{"key":"61819_CR9","doi-asserted-by":"publisher","first-page":"4053","DOI":"10.3748\/wjg.v28.i30.4053","volume":"28","author":"AEV Quaglio","year":"2022","unstructured":"Quaglio, A. E. V., Grillo, T. G., De Oliveira, E. C. S., Di Stasi, L. C. & Sassaki, L. Y. Gut microbiota, inflammatory bowel disease and colorectal cancer. World J. Gastroenterol. 28, 4053\u20134060. https:\/\/doi.org\/10.3748\/wjg.v28.i30.4053 (2022).","journal-title":"World J. Gastroenterol."},{"key":"61819_CR10","doi-asserted-by":"publisher","first-page":"1499203","DOI":"10.3389\/fcimb.2024.1499203","volume":"14","author":"H Guo","year":"2024","unstructured":"Guo, H. Interactions between the tumor microbiota and breast cancer. Front. Cell. Infect. Microbiol. 14, 1499203. https:\/\/doi.org\/10.3389\/fcimb.2024.1499203 (2024).","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"61819_CR11","doi-asserted-by":"publisher","first-page":"3789","DOI":"10.1016\/j.cell.2022.09.005","volume":"185","author":"L Narunsky-Haziza","year":"2022","unstructured":"Narunsky-Haziza, L. et al. Pan-cancer analyses reveal cancer-type-specific fungal ecologies and bacteriome interactions. Cell 185, 3789\u20133806e3717. https:\/\/doi.org\/10.1016\/j.cell.2022.09.005 (2022).","journal-title":"Cell"},{"key":"61819_CR12","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1126\/science.aay9189","volume":"368","author":"D Nejman","year":"2020","unstructured":"Nejman, D. et al. The human tumor microbiome is composed of tumor type-specific intracellular bacteria. Science 368, 973\u2013980. https:\/\/doi.org\/10.1126\/science.aay9189 (2020).","journal-title":"Science"},{"key":"61819_CR13","doi-asserted-by":"publisher","first-page":"e38310","DOI":"10.1016\/j.heliyon.2024.e38310","volume":"10","author":"H Xu","year":"2024","unstructured":"Xu, H. et al. Tumor microbiota of renal cell carcinoma affects clinical prognosis by influencing the tumor immune microenvironment. Heliyon 10, e38310. https:\/\/doi.org\/10.1016\/j.heliyon.2024.e38310 (2024).","journal-title":"Heliyon"},{"key":"61819_CR14","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1089\/omi.2011.0118","volume":"16","author":"G Yu","year":"2012","unstructured":"Yu, G., Wang, L. G., Han, Y. & He, Q. Y. clusterProfiler: an R package for comparing biological themes among gene clusters. Omics 16, 284\u2013287. https:\/\/doi.org\/10.1089\/omi.2011.0118 (2012).","journal-title":"Omics"},{"key":"61819_CR15","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1038\/s41579-019-0213-6","volume":"17","author":"M Schirmer","year":"2019","unstructured":"Schirmer, M., Garner, A., Vlamakis, H. & Xavier, R. J. Microbial genes and pathways in inflammatory bowel disease. Nat. Rev. Microbiol. 17, 497\u2013511. https:\/\/doi.org\/10.1038\/s41579-019-0213-6 (2019).","journal-title":"Nat. Rev. Microbiol."},{"key":"61819_CR16","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1385\/jmn:30:1:51","volume":"30","author":"MF Montenegro","year":"2006","unstructured":"Montenegro, M. F. et al. Acetyl- and butyrylcholinesterase activities decrease in human colon adenocarcinoma. J. Mol. Neurosci. 30, 51\u201354. https:\/\/doi.org\/10.1385\/jmn:30:1:51 (2006).","journal-title":"J. Mol. Neurosci."},{"key":"61819_CR17","doi-asserted-by":"publisher","first-page":"1356","DOI":"10.1016\/j.cell.2022.02.027","volume":"185","author":"A Fu","year":"2022","unstructured":"Fu, A. et al. Tumor-resident intracellular microbiota promotes metastatic colonization in breast cancer. Cell 185, 1356\u20131372e1326. https:\/\/doi.org\/10.1016\/j.cell.2022.02.027 (2022).","journal-title":"Cell"},{"key":"61819_CR18","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1007\/s13539-012-0083-5","volume":"4","author":"L Santarpia","year":"2013","unstructured":"Santarpia, L., Grandone, I., Contaldo, F. & Pasanisi, F. Butyrylcholinesterase as a prognostic marker: a review of the literature. J. Cachexia Sarcopenia Muscle. 4, 31\u201339. https:\/\/doi.org\/10.1007\/s13539-012-0083-5 (2013).","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"61819_CR19","doi-asserted-by":"publisher","first-page":"e0149183","DOI":"10.1371\/journal.pone.0149183","volume":"11","author":"S Willis","year":"2016","unstructured":"Willis, S. et al. Single gene prognostic biomarkers in ovarian cancer: A meta-analysis. PLoS One. 11, e0149183. https:\/\/doi.org\/10.1371\/journal.pone.0149183 (2016).","journal-title":"PLoS One"},{"key":"61819_CR20","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1016\/j.tranon.2018.06.003","volume":"11","author":"Y Gu","year":"2018","unstructured":"Gu, Y. et al. Biphasic alteration of butyrylcholinesterase (BChE) during prostate cancer development. Transl. Oncol. 11, 1012\u20131022. https:\/\/doi.org\/10.1016\/j.tranon.2018.06.003 (2018).","journal-title":"Transl. Oncol."},{"key":"61819_CR21","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.cbi.2016.02.013","volume":"259","author":"S Brimijoin","year":"2016","unstructured":"Brimijoin, S., Chen, V. P., Pang, Y. P., Geng, L. & Gao, Y. Physiological roles for butyrylcholinesterase: A BChE-ghrelin axis. Chem. Biol. Interact. 259, 271\u2013275. https:\/\/doi.org\/10.1016\/j.cbi.2016.02.013 (2016).","journal-title":"Chem. Biol. Interact."},{"key":"61819_CR22","doi-asserted-by":"publisher","first-page":"112","DOI":"10.3389\/fphar.2018.00112","volume":"9","author":"S Brimijoin","year":"2018","unstructured":"Brimijoin, S., Gao, Y., Geng, L. & Chen, V. P. Treating cocaine addiction, obesity, and emotional disorders by viral gene transfer of butyrylcholinesterase. Front. Pharmacol. 9, 112. https:\/\/doi.org\/10.3389\/fphar.2018.00112 (2018).","journal-title":"Front. Pharmacol."},{"key":"61819_CR23","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/j.canlet.2014.01.031","volume":"356","author":"N Wong","year":"2015","unstructured":"Wong, N., Ojo, D., Yan, J. & Tang, D. PKM2 contributes to cancer metabolism. Cancer Lett. 356, 184\u2013191. https:\/\/doi.org\/10.1016\/j.canlet.2014.01.031 (2015).","journal-title":"Cancer Lett."},{"key":"61819_CR24","doi-asserted-by":"publisher","first-page":"e27011","DOI":"10.1016\/j.heliyon.2024.e27011","volume":"10","author":"RS Patwardhan","year":"2024","unstructured":"Patwardhan, R. S., Rai, A., Sharma, D., Sandur, S. K. & Patwardhan, S. Txnrd1 as a prognosticator for recurrence, metastasis and response to neoadjuvant chemotherapy and radiotherapy in breast cancer patients. Heliyon 10, e27011. https:\/\/doi.org\/10.1016\/j.heliyon.2024.e27011 (2024).","journal-title":"Heliyon"},{"key":"61819_CR25","doi-asserted-by":"publisher","first-page":"107461","DOI":"10.1016\/j.envint.2022.107461","volume":"168","author":"T Xu","year":"2022","unstructured":"Xu, T. et al. Systematic identification of molecular mechanisms for aryl hydrocarbon receptor mediated neuroblastoma cell migration. Environ. Int. 168, 107461. https:\/\/doi.org\/10.1016\/j.envint.2022.107461 (2022).","journal-title":"Environ. Int."},{"key":"61819_CR26","doi-asserted-by":"publisher","first-page":"2006","DOI":"10.1021\/acs.jnatprod.2c00400","volume":"85","author":"X Hao","year":"2022","unstructured":"Hao, X. et al. Network pharmacology research and dual-omic analyses reveal the molecular mechanism of natural product nodosin inhibiting muscle-invasive bladder cancer in vitro and in vivo. J. Nat. Prod. 85, 2006\u20132017. https:\/\/doi.org\/10.1021\/acs.jnatprod.2c00400 (2022).","journal-title":"J. Nat. Prod."},{"key":"61819_CR27","doi-asserted-by":"publisher","first-page":"1934","DOI":"10.1158\/0008-5472.Can-04-3626","volume":"65","author":"JF de Groot","year":"2005","unstructured":"de Groot, J. F., Liu, T. J., Fuller, G. & Yung, W. K. The excitatory amino acid transporter-2 induces apoptosis and decreases glioma growth in vitro and in vivo. Cancer Res. 65, 1934\u20131940. https:\/\/doi.org\/10.1158\/0008-5472.Can-04-3626 (2005).","journal-title":"Cancer Res."},{"key":"61819_CR28","doi-asserted-by":"publisher","first-page":"77ra30","DOI":"10.1126\/scitranslmed.3001423","volume":"3","author":"J Tao","year":"2011","unstructured":"Tao, J. et al. CD44-SLC1A2 gene fusions in gastric cancer. Sci. Transl. Med. 3, 77ra30. https:\/\/doi.org\/10.1126\/scitranslmed.3001423 (2011).","journal-title":"Sci. Transl. Med."},{"key":"61819_CR29","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1186\/s12885-015-1405-8","volume":"15","author":"E Pedraz-Cuesta","year":"2015","unstructured":"Pedraz-Cuesta, E. et al. The glutamate transport inhibitor DL-Threo-\u03b2-Benzyloxyaspartic acid (DL-TBOA) differentially affects SN38- and oxaliplatin-induced death of drug-resistant colorectal cancer cells. BMC Cancer. 15, 411. https:\/\/doi.org\/10.1186\/s12885-015-1405-8 (2015).","journal-title":"BMC Cancer"},{"key":"61819_CR30","doi-asserted-by":"publisher","first-page":"e102147","DOI":"10.15252\/embj.2019102147","volume":"38","author":"J Sun","year":"2019","unstructured":"Sun, J. et al. SLC1A3 contributes to L-asparaginase resistance in solid tumors. Embo J. 38, e102147. https:\/\/doi.org\/10.15252\/embj.2019102147 (2019).","journal-title":"Embo J."},{"key":"61819_CR31","doi-asserted-by":"publisher","first-page":"1268","DOI":"10.1007\/s11064-019-02934-x","volume":"45","author":"N Freidman","year":"2020","unstructured":"Freidman, N. et al. Amino acid transporters and exchangers from the SLC1A family: Structure, mechanism and roles in physiology and cancer. Neurochem. Res. 45, 1268\u20131286. https:\/\/doi.org\/10.1007\/s11064-019-02934-x (2020).","journal-title":"Neurochem. Res."},{"key":"61819_CR32","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1158\/0008-5472.Can-20-0617","volume":"81","author":"W Guo","year":"2021","unstructured":"Guo, W. et al. Dysregulated glutamate transporter SLC1A1 propels cystine uptake via Xc(-) for glutathione synthesis in lung cancer. Cancer Res. 81, 552\u2013566. https:\/\/doi.org\/10.1158\/0008-5472.Can-20-0617 (2021).","journal-title":"Cancer Res."},{"key":"61819_CR33","doi-asserted-by":"publisher","unstructured":"Fu, S. et al. Glutamine synthetase promotes radiation resistance via facilitating nucleotide metabolism and subsequent DNA damage repair. Cell Rep. 28, 1136\u20131143.e1134. https:\/\/doi.org\/10.1016\/j.celrep.2019.07.002 (2019).","DOI":"10.1016\/j.celrep.2019.07.002"},{"key":"61819_CR34","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1038\/s41556-018-0118-z","volume":"20","author":"J Garcia-Bermudez","year":"2018","unstructured":"Garcia-Bermudez, J. et al. Aspartate is a limiting metabolite for cancer cell proliferation under hypoxia and in tumours. Nat. Cell. Biol. 20, 775\u2013781. https:\/\/doi.org\/10.1038\/s41556-018-0118-z (2018).","journal-title":"Nat. Cell. Biol."},{"key":"61819_CR35","doi-asserted-by":"publisher","first-page":"629264","DOI":"10.3389\/fphar.2021.629264","volume":"12","author":"W Hao","year":"2021","unstructured":"Hao, W. et al. Radioresistant nasopharyngeal carcinoma cells exhibited decreased cisplatin sensitivity by inducing SLC1A6 expression. Front. Pharmacol. 12, 629264. https:\/\/doi.org\/10.3389\/fphar.2021.629264 (2021).","journal-title":"Front. Pharmacol."},{"key":"61819_CR36","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.3892\/or.2021.7945","volume":"45","author":"SQ An","year":"2021","unstructured":"An, S. Q. et al. Low microRNA150 expression is associated with activated carcinogenic pathways and a poor prognosis in patients with breast cancer. Oncol. Rep. 45, 1235\u20131248. https:\/\/doi.org\/10.3892\/or.2021.7945 (2021).","journal-title":"Oncol. Rep."},{"key":"61819_CR37","doi-asserted-by":"publisher","first-page":"1715","DOI":"10.1093\/nar\/gkz1206","volume":"48","author":"S An","year":"2020","unstructured":"An, S. et al. Integrative network analysis identifies cell-specific trans regulators of m6A. Nucleic Acids Res. 48, 1715\u20131729. https:\/\/doi.org\/10.1093\/nar\/gkz1206 (2020).","journal-title":"Nucleic Acids Res."},{"key":"61819_CR38","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.eururo.2019.01.011","volume":"76","author":"JA Efstathiou","year":"2019","unstructured":"Efstathiou, J. A. et al. Impact of immune and stromal infiltration on outcomes following bladder-sparing trimodality therapy for muscle-invasive bladder cancer. Eur. Urol. 76, 59\u201368. https:\/\/doi.org\/10.1016\/j.eururo.2019.01.011 (2019).","journal-title":"Eur. Urol."},{"key":"61819_CR39","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.1038\/nm.3394","volume":"19","author":"DF Quail","year":"2013","unstructured":"Quail, D. F. & Joyce, J. A. Microenvironmental regulation of tumor progression and metastasis. Nat. Med. 19, 1423\u20131437. https:\/\/doi.org\/10.1038\/nm.3394 (2013).","journal-title":"Nat. Med."},{"key":"61819_CR40","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1038\/nrd.2018.169","volume":"17","author":"L Cassetta","year":"2018","unstructured":"Cassetta, L. & Pollard, J. W. Targeting macrophages: therapeutic approaches in cancer. Nat. Rev. Drug Discov. 17, 887\u2013904. https:\/\/doi.org\/10.1038\/nrd.2018.169 (2018).","journal-title":"Nat. Rev. Drug Discov"},{"key":"61819_CR41","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1007\/s00262-018-2289-7","volume":"68","author":"R Zhou","year":"2019","unstructured":"Zhou, R. et al. Immune cell infiltration as a biomarker for the diagnosis and prognosis of stage I-III colon cancer. Cancer Immunol. Immunother. 68, 433\u2013442. https:\/\/doi.org\/10.1007\/s00262-018-2289-7 (2019).","journal-title":"Cancer Immunol. Immunother"},{"key":"61819_CR42","doi-asserted-by":"publisher","first-page":"1218","DOI":"10.3389\/fimmu.2020.01218","volume":"11","author":"S Zuo","year":"2020","unstructured":"Zuo, S., Wei, M., Wang, S., Dong, J. & Wei, J. Pan-cancer analysis of immune cell infiltration identifies a prognostic immune-cell characteristic score (ICCS) in lung adenocarcinoma. Front. Immunol. 11, 1218. https:\/\/doi.org\/10.3389\/fimmu.2020.01218 (2020).","journal-title":"Front. Immunol."},{"key":"61819_CR43","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1038\/nri3789","volume":"15","author":"T Kitamura","year":"2015","unstructured":"Kitamura, T., Qian, B. Z. & Pollard, J. W. Immune cell promotion of metastasis. Nat. Rev. Immunol. 15, 73\u201386. https:\/\/doi.org\/10.1038\/nri3789 (2015).","journal-title":"Nat. Rev. Immunol."},{"key":"61819_CR44","doi-asserted-by":"publisher","first-page":"2425","DOI":"10.1172\/jci66375","volume":"124","author":"CA Bauer","year":"2014","unstructured":"Bauer, C. A. et al. Dynamic Treg interactions with intratumoral APCs promote local CTL dysfunction. J. Clin. Investig. 124, 2425\u20132440. https:\/\/doi.org\/10.1172\/jci66375 (2014).","journal-title":"J. Clin. Investig."},{"key":"61819_CR45","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/j.ccr.2012.07.023","volume":"22","author":"P Yang","year":"2012","unstructured":"Yang, P. et al. TGF-\u03b2-miR-34a-CCL22 signaling-induced Treg cell recruitment promotes venous metastases of HBV-positive hepatocellular carcinoma. Cancer Cell. 22, 291\u2013303. https:\/\/doi.org\/10.1016\/j.ccr.2012.07.023 (2012).","journal-title":"Cancer Cell."},{"key":"61819_CR46","doi-asserted-by":"publisher","first-page":"1909","DOI":"10.1016\/s0140-6736(16)00561-4","volume":"387","author":"JE Rosenberg","year":"2016","unstructured":"Rosenberg, J. E. et al. Atezolizumab in patients with locally advanced and metastatic urothelial carcinoma who have progressed following treatment with platinum-based chemotherapy: a single-arm, multicentre, phase 2 trial. Lancet 387, 1909\u20131920. https:\/\/doi.org\/10.1016\/s0140-6736(16)00561-4 (2016).","journal-title":"Lancet"},{"key":"61819_CR47","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/s0140-6736(16)32455-2","volume":"389","author":"AV Balar","year":"2017","unstructured":"Balar, A. V. et al. Atezolizumab as first-line treatment in cisplatin-ineligible patients with locally advanced and metastatic urothelial carcinoma: a single-arm, multicentre, phase 2 trial. Lancet 389, 67\u201376. https:\/\/doi.org\/10.1016\/s0140-6736(16)32455-2 (2017).","journal-title":"Lancet"},{"key":"61819_CR48","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1016\/s1470-2045(17)30065-7","volume":"18","author":"P Sharma","year":"2017","unstructured":"Sharma, P. et al. Nivolumab in metastatic urothelial carcinoma after platinum therapy (CheckMate 275): a multicentre, single-arm, phase 2 trial. Lancet Oncol. 18, 312\u2013322. https:\/\/doi.org\/10.1016\/s1470-2045(17)30065-7 (2017).","journal-title":"Lancet Oncol."},{"key":"61819_CR49","doi-asserted-by":"publisher","first-page":"1706","DOI":"10.1038\/s41591-019-0628-7","volume":"25","author":"T Powles","year":"2019","unstructured":"Powles, T. et al. Clinical efficacy and biomarker analysis of neoadjuvant atezolizumab in operable urothelial carcinoma in the ABACUS trial. Nat. Med. 25, 1706\u20131714. https:\/\/doi.org\/10.1038\/s41591-019-0628-7 (2019).","journal-title":"Nat. Med."},{"key":"61819_CR50","doi-asserted-by":"publisher","unstructured":"Liu, Z., An, S. & Li, W. Artificial intelligence in immunoinformatics: From multi-omics to precision immunology. iCell. 2, 180\u2013183. https:\/\/doi.org\/10.71373\/SAOV9257 (2025).","DOI":"10.71373\/SAOV9257"},{"key":"61819_CR51","doi-asserted-by":"publisher","unstructured":"Grayson, M. Bladder cancer. Nature. 551 (S33). https:\/\/doi.org\/10.1038\/551S33a (2017).","DOI":"10.1038\/551S33a"},{"key":"61819_CR52","doi-asserted-by":"publisher","first-page":"966","DOI":"10.1016\/j.eururo.2014.08.029","volume":"66","author":"DM Maghdid","year":"2014","unstructured":"Maghdid, D. M. & Kok, D. J. Words of wisdom. Re: urine is not sterile: use of enhanced urine culture techniques to detect resident bacterial flora in the adult female bladder. Eur. Urol. 66, 966. https:\/\/doi.org\/10.1016\/j.eururo.2014.08.029 (2014).","journal-title":"Eur. Urol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-61819-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-61819-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-61819-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T16:03:40Z","timestamp":1791907420000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-61819-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,11]]},"references-count":52,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["61819"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-61819-6","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,11]]},"assertion":[{"value":"20 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Ethics Committees of both Wuxi Second People\u2019s Hospital and Jiangsu Province Hospital (Approval No.: 2023 Ethical Review No. (Y-167)). Written informed consent was obtained from all participants. All procedures were performed in accordance with the Helsinki Declaration.","order":2,"name":"Ethics","label":"Ethics approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Written informed consent was obtained from all participants.","order":3,"name":"Ethics","label":"Consent to participate and consent to publish","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"31947"}}